{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:08Z","timestamp":1792631468498,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.msard.2024.106209","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T15:00:27Z","timestamp":1733065227000},"page":"106209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Relapse risk factors analysis within 1 year after the first onset of neuromyelitis optica spectrum disorders: A two-center retrospective study"],"prefix":"10.1016","volume":"93","author":[{"given":"Houde","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2024.106209_bib0001","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammat."},{"key":"10.1016\/j.msard.2024.106209_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.628024","article-title":"An abnormally high neutrophil-to-lymphocyte ratio is not an independent outcome predictor in AQP4-IgG-positive NMOSD","volume":"12","author":"Carnero Contentti","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.msard.2024.106209_bib0003","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10072-018-3248-y","article-title":"The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder","volume":"39","author":"Cho","year":"2018","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.msard.2024.106209_bib0004","first-page":"1131","article-title":"Neuromyelitis optica spectrum disorders","volume":"28","author":"Costello","year":"2022","journal-title":"Continuum (Minneap. Minn.)"},{"issue":"8","key":"10.1016\/j.msard.2024.106209_bib0005","first-page":"700","article-title":"The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis","volume":"126","author":"Demirci","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2024.106209_bib0006","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jocn.2019.11.022","article-title":"The differential expression of natural killer cells in NMOSD and MS","volume":"71","author":"Ding","year":"2020","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.msard.2024.106209_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","article-title":"Clinical characteristics, course and prognosis of relapsing Devic's neuromyelitis optica","volume":"251","author":"Ghezzi","year":"2004","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.106209_bib0008","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1352458516687043","article-title":"Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders","volume":"23","author":"Huh","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.106209_bib0009","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammat."},{"issue":"11","key":"10.1016\/j.msard.2024.106209_bib0010","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/archneurol.2011.154","article-title":"Repeated treatment with rituximab based on the assessment of peripheral circulating memory B cells in patients with relapsing neuromyelitis optica over 2 years","volume":"68","author":"Kim","year":"2011","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2024.106209_bib0011","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s10072-017-3068-5","article-title":"Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD","volume":"38","author":"Lin","year":"2017","journal-title":"Neurolog. Sci.: Off. J. Ital. Neurolog. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.msard.2024.106209_bib0012","first-page":"58","article-title":"The pathologic and diagnostic in magnetic resonance imaging of brain and cervical spine of patients with neuromyelitis optica spectrum disorder","volume":"17","author":"Mehdipour-Dastjerdi","year":"2018","journal-title":"Iran J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2024.106209_bib0013","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10072-003-0098-y","article-title":"Neuromyelitis optica: importance of cerebrospinal fluid examination during relapse","volume":"24","author":"Milano","year":"2003","journal-title":"Neurolog. Sci.: Off. J. Ital. Neurolog. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.msard.2024.106209_bib0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2024.106209_bib0015","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni1494","article-title":"Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells","volume":"8","author":"Phan","year":"2007","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2024.106209_bib0016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1590\/0004-282X20160044","article-title":"Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry","volume":"74","author":"Reiber","year":"2016","journal-title":"Arquivos de Neuro-Psiquiatria"},{"key":"10.1016\/j.msard.2024.106209_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2021.577666","article-title":"Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder","volume":"358","author":"Sechi","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.msard.2024.106209_bib0018","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-019-09649-7","article-title":"Effects of immunotherapies and prognostic predictors in neuromyelitis optica spectrum disorder: a prospective cohort study","volume":"267","author":"Shi","year":"2020","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2024.106209_bib0019","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/1352458518792430","article-title":"A nationwide epidemiological study on the prevalence of multiple sclerosis and neuromyelitis optica spectrum disorder with important multi-ethnic differences in Malaysia","volume":"25","author":"Viswanathan","year":"2019","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2024.106209_bib0020","article-title":"Neuromyelitis optica spectrum disorder with anti-aquaporin-4 antibody: outcome prediction models","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2024.106209_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2024.106209_bib0022","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2016.04.006","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.msard.2024.106209_bib0023","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12883-021-02432-0","article-title":"Association of neutrophil-to-lymphocyte ratio (NLR) with the prognosis of first attack neuromyelitis optica spectrum disorder (NMOSD): a retrospective cohort study","volume":"21","author":"Xie","year":"2021","journal-title":"BMC Neurol."},{"issue":"4","key":"10.1016\/j.msard.2024.106209_bib0024","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000520745","article-title":"Lymphocyte subsets are associated with disease status in neuromyelitis optica spectrum disorders","volume":"29","author":"Yang","year":"2022","journal-title":"Neuroimmunomodulation"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824007855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034824007855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T20:59:15Z","timestamp":1738184355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034824007855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"alternative-id":["S2211034824007855"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2024.106209","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relapse risk factors analysis within 1 year after the first onset of neuromyelitis optica spectrum disorders: A two-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2024.106209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106209"}}